214 related articles for article (PubMed ID: 36170757)
1. Psychopathology among anabolic-androgenic steroid using and non-using female athletes in Norway.
Scarth M; Jørstad ML; Reierstad A; Klonteig S; Torgersen S; Hullstein IR; Bjørnebekk A
J Psychiatr Res; 2022 Nov; 155():295-301. PubMed ID: 36170757
[TBL] [Abstract][Full Text] [Related]
2. Clustering psychopathology in male anabolic-androgenic steroid users and nonusing weightlifters.
Jørstad ML; Scarth M; Torgersen S; Pope HG; Bjørnebekk A
Brain Behav; 2023 Jul; 13(7):e3040. PubMed ID: 37150843
[TBL] [Abstract][Full Text] [Related]
3. Anabolic-androgenic steroid use and psychopathology in athletes. A systematic review.
Piacentino D; Kotzalidis GD; Del Casale A; Aromatario MR; Pomara C; Girardi P; Sani G
Curr Neuropharmacol; 2015 Jan; 13(1):101-21. PubMed ID: 26074746
[TBL] [Abstract][Full Text] [Related]
4. Anabolic androgenic steroids, antisocial personality traits, aggression and violence.
Hauger LE; Havnes IA; Jørstad ML; Bjørnebekk A
Drug Alcohol Depend; 2021 Apr; 221():108604. PubMed ID: 33621808
[TBL] [Abstract][Full Text] [Related]
5. Investigating anabolic-androgenic steroid dependence and muscle dysmorphia with network analysis among male weightlifters.
Scarth M; Westlye LT; Havnes IA; Bjørnebekk A
BMC Psychiatry; 2023 May; 23(1):342. PubMed ID: 37193971
[TBL] [Abstract][Full Text] [Related]
6. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
7. Gendered perspectives on women's anabolic-androgenic steroid (AAS) usage practices.
Piatkowski T; Robertson J; Lamon S; Dunn M
Harm Reduct J; 2023 Apr; 20(1):56. PubMed ID: 37098574
[TBL] [Abstract][Full Text] [Related]
8. Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings.
Piacentino D; Sani G; Kotzalidis GD; Cappelletti S; Longo L; Rizzato S; Fabi F; Frati P; Fineschi V; Leggio L
Hum Psychopharmacol; 2022 Jan; 37(1):e2815. PubMed ID: 34528289
[TBL] [Abstract][Full Text] [Related]
9. Theory of mind in users of anabolic androgenic steroids.
Vaskinn A; Hauger LE; Bjørnebekk A
Psychopharmacology (Berl); 2020 Oct; 237(10):3191-3199. PubMed ID: 32623552
[TBL] [Abstract][Full Text] [Related]
10. Sudden Cardiac Death in Anabolic-Androgenic Steroid Users: A Literature Review.
Torrisi M; Pennisi G; Russo I; Amico F; Esposito M; Liberto A; Cocimano G; Salerno M; Li Rosi G; Di Nunno N; Montana A
Medicina (Kaunas); 2020 Nov; 56(11):. PubMed ID: 33158202
[No Abstract] [Full Text] [Related]
11. Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users.
Griffiths S; Jacka B; Degenhardt L; Murray SB; Larance B
Drug Alcohol Rev; 2018 Jul; 37(5):664-670. PubMed ID: 29484740
[TBL] [Abstract][Full Text] [Related]
12. Anabolic steroid use and body image psychopathology in men: Delineating between appearance- versus performance-driven motivations.
Murray SB; Griffiths S; Mond JM; Kean J; Blashill AJ
Drug Alcohol Depend; 2016 Aug; 165():198-202. PubMed ID: 27364377
[TBL] [Abstract][Full Text] [Related]
13. Psychiatric and medical effects of anabolic-androgenic steroid use in women.
Gruber AJ; Pope HG
Psychother Psychosom; 2000; 69(1):19-26. PubMed ID: 10601831
[TBL] [Abstract][Full Text] [Related]
14. Anabolic Androgenic Steroid Use Patterns and Steroid Use Disorders in a Sample of Male Gym Visitors.
de Zeeuw TI; Brunt TM; van Amsterdam J; van de Ven K; van den Brink W
Eur Addict Res; 2023; 29(2):99-108. PubMed ID: 36731448
[TBL] [Abstract][Full Text] [Related]
15. Severity of anabolic steroid dependence, executive function, and personality traits in substance use disorder patients in Norway.
Scarth M; Havnes IA; Jørstad ML; McVeigh J; Van Hout MC; Westlye LT; Torgersen S; Bjørnebekk A
Drug Alcohol Depend; 2022 Feb; 231():109275. PubMed ID: 35030506
[TBL] [Abstract][Full Text] [Related]
16. The Central Effects of Androgenic-anabolic Steroid Use.
Mędraś M; Brona A; Jóźków P
J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
[TBL] [Abstract][Full Text] [Related]
17. Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids.
Abdullah R; Bjørnebekk A; Hauger LE; Hullstein IR; Edvardsen T; Haugaa KH; Almaas VM
Eur J Prev Cardiol; 2024 Mar; 31(5):599-608. PubMed ID: 37992194
[TBL] [Abstract][Full Text] [Related]
18. Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study.
Henriksen HCB; Havnes IA; Jørstad ML; Bjørnebekk A
Subst Abuse Treat Prev Policy; 2023 Apr; 18(1):19. PubMed ID: 37013635
[TBL] [Abstract][Full Text] [Related]
19. Anabolic-androgenic steroids are linked to depression and anxiety in male bodybuilders: the hidden psychogenic side of anabolic androgenic steroids.
Karagun B; Altug S
Ann Med; 2024 Dec; 56(1):2337717. PubMed ID: 38590148
[TBL] [Abstract][Full Text] [Related]
20. Personality profile of men using anabolic androgenic steroids.
Galligani N; Renck A; Hansen S
Horm Behav; 1996 Jun; 30(2):170-5. PubMed ID: 8797026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
